Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S-I Yamagishi

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Molecular Medicine|March 19, 2010
Anti-atherothrombogenic properties of PEDFS-I Yamagishi, T Matsui
Current Molecular Medicine|March 19, 2010
PEDF and septic shockT Nakamura, S-I Yamagishi
Current Molecular Medicine|March 19, 2010
Development of enzyme-linked immunosorbent assay system for PEDF and its clinical utilityK Fukami, S-I Yamagishi, S Okuda
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 17, 2008
Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patientsS-I Yamagishi, T Matsui, K Nakamura
Current Molecular Medicine|March 19, 2010
Structure-function relationships of PEDFT Kawaguchi, S-I Yamagishi, M Sata
Current Molecular Medicine|March 19, 2010
Anti-vasopermeability effects of PEDF in retinal-renal disordersS Ueda, S-I Yamagishi, S Okuda
The Journal of International Medical Research|June 3, 2010
Positive association of serum levels of pigment epithelium-derived factor with high-sensitivity C-reactive protein in apparently healthy unmedicated subjectsH Umei, S-I Yamagishi, T Imaizumi
Current Molecular Medicine|March 19, 2010
The role of PEDF in tumor growth and metastasisD Hoshina, R Abe, S-I Yamagishi, et al.
Journal of Endocrinological Investigation|January 15, 2005
Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectinS I Yamagishi, T Suzuki, H Ohkuro, et al.
Current Medicinal Chemistry|April 29, 2010
Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disordersS-I Yamagishi, T Matsui, T Kawaguchi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Molecular Medicine|March 19, 2010
Anti-atherothrombogenic properties of PEDFS-I Yamagishi, T Matsui
Current Molecular Medicine|March 19, 2010
PEDF and septic shockT Nakamura, S-I Yamagishi
Current Molecular Medicine|March 19, 2010
Development of enzyme-linked immunosorbent assay system for PEDF and its clinical utilityK Fukami, S-I Yamagishi, S Okuda
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 17, 2008
Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patientsS-I Yamagishi, T Matsui, K Nakamura
Current Molecular Medicine|March 19, 2010
Structure-function relationships of PEDFT Kawaguchi, S-I Yamagishi, M Sata
Current Molecular Medicine|March 19, 2010
Anti-vasopermeability effects of PEDF in retinal-renal disordersS Ueda, S-I Yamagishi, S Okuda
The Journal of International Medical Research|June 3, 2010
Positive association of serum levels of pigment epithelium-derived factor with high-sensitivity C-reactive protein in apparently healthy unmedicated subjectsH Umei, S-I Yamagishi, T Imaizumi
Current Molecular Medicine|March 19, 2010
The role of PEDF in tumor growth and metastasisD Hoshina, R Abe, S-I Yamagishi, et al.
Journal of Endocrinological Investigation|January 15, 2005
Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectinS I Yamagishi, T Suzuki, H Ohkuro, et al.
Current Medicinal Chemistry|April 29, 2010
Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disordersS-I Yamagishi, T Matsui, T Kawaguchi, et al.
Pageof 3